The winners were announced at this year’s event held on
The Company was named for the Solésence Kleair™ technology, which is available exclusively through Solésence finished goods. The innovation optimizes zinc oxide to improve its efficacy and aesthetics while boasting best-in-class skin health claims and retaining the purity to meet global requirements.
Solésence Kleair™ enables the active prevention of skin damage caused by UV and pollution by intercepting and quenching exogenous free radicals before they enter the skin, preventing lipid peroxidation while preserving the efficacy of antioxidants. In this way, the technology solves critical health and accessibility issues in the beauty space, making vital, best-in-class skin health products accessible to people of all skin tones, and enabling the development and commercialization of new textures and formats in the mineral space.
“The Chicago region continues to be a global leader in innovation,” said
“We are thrilled to receive this award and be recognized among the leading innovators in
“At Solésence, innovation is at the heart of what we do. Beyond simply providing best-in-class sun care, Solésence Kleair™ is designed to protect against pollution and enhance the activity of antioxidants and other actives. Through this type of innovation, we continue to help our brand partners bring powerful, innovative, life changing skincare to everyone,” commented
The winning organizations receive a variety of honors including the opportunity to ring the Nasdaq Bell in
“Nearly 350 organizations were nominated for this year’s awards,” said
The complete list of this year’s Chicago Innovation Award winners can be found at www.chicagoinnovation.com.
About Solésence Beauty Science
Solésence, LLC, www.solesence.com, a wholly owned subsidiary of
About
Forward-Looking Statements
This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed
Solésence Media Contact:
kkruslak@solesence.com
(630) 402-6056
Nanophase Investor Relations Contact:
(630) 771-6736
Chicago Innovation Contact:
Luke@chicagoinnovation.com
(312) 988-1516
Source:
2023 GlobeNewswire, Inc., source